Clinical Study

Evaluation Of Lunar Test In Average Patient Screening For Colon Cancer

Posted Date: Sep 20, 2021

  • Investigator: Loren Brook
  • Specialties: Colorectal Cancer, Gastroenterology
  • Type of Study: Observational/Survey

The LUNAR-2 blood test has been developed to detect malignant disease in screen-relevant patients who would otherwise undergo screening for malignant disease using invasive methodologies such as colonoscopy. This study will perform a blood draw prior to the patient undergoing the standard of care colonoscopy (and all associated preparatory medications) and retrospectively compare the performance characteristics of the LUNAR-2 test with the findings of the colonoscopy. Outcomes of patients at one and two-years post-procedure will be collected as secondary endpoints.


Key Inclusion: Age 60-84 Years Of Age. Intended To Undergo A Screening Colonoscopy. Considered By Physician To Be Of "Average Risk" For Colorectal Cancer. Willing To Consent To Blood Draw Pre-Bowel Prep For Colonoscopy. Key Exclusion: Undergoing Colonoscopy For Investigation Of Symptoms. Has Undergone Colonoscopy In The Past 9 Years. Completed A Cologuard Test In The Past 3 Year. History Of Malignancy. Known Diagnosis Of Inflammatory Bowel Disease. Family History Of Colorectal Cancer.


Colonoscopy, Screening, Colon Cancer

For More Information:

Missy Randolph

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.